Accelerated fractionation radiotherapy and concomitant chemotherapy in patients with stage IV inoperable head and neck cancer
- 1 November 1995
- Vol. 76 (9) , 1655-1661
- https://doi.org/10.1002/1097-0142(19951101)76:9<1655::aid-cncr2820760923>3.0.co;2-q
Abstract
Background. Stage IV inoperable head and neck cancer has a 2-year mortality rate of greater than 70% when treated with conventional radiotherapy. A Phase II study was undertaken to evaluate the effects of concomitant chemotherapy and accelerated, interrupted, twice-a-day radiotherapy on tumor response, locoregional control, survival, and morbidity. Methods. Thirty-four patients with Stage IV inoperable squamous cell carcinoma of the head and neck and a minimum follow-up of 36 months were evaluated. Concomitant chemoradiotherapy was administered during weeks 1, 3, and 5 (with planned breaks during weeks 2 and 4), consisting of cisplatin 60 mg/m2 on Day 1, continuous 5-day infusion of 5-fluorouracil, 750 mg/m2 per day, and radiotherapy, 2 Gy twice a day, more than 6 hours apart, followed by 3 days of radiation therapy alone (final “boost”) in week 6, for a total dose of 70 Gy and treatment duration of 5½ weeks (38 days). Results. Twenty-seven patients achieved a clinical complete response (82%). Actuarial locoregional control at 3 years was 73% and the actuarial 3-year survival probability, including all deaths, was 38%. All locoregional recurrences were manifested within 12 months. Of the 20 deaths, 12 were tumor related (locoregional and/or metastatic), 3 were treatment related, and 5 were due to other causes. Acute toxicity consisted of grade 3 mucositis and dysphagia and grade 2–3 leukopenia, not requiring treatment interruption or cessation. Conclusion. Concomitant accelerated radiation therapy and chemotherapy is a feasible treatment approach in this prognostically poor patient population, yielding dramatic tumor responses and impressive locoregional control at the cost of somewhat increased acute toxicity. Although serious late complications have not been observed, caution should be exercised in view of the relatively short follow up. Cancer 1995; 76:1655–61.Keywords
This publication has 21 references indexed in Scilit:
- Simultaneous Chemoradiation in the Treatment of Advanced Head and Neck CancerJAMA Otolaryngology–Head & Neck Surgery, 1992
- Experience with CHARTInternational Journal of Radiation Oncology*Biology*Physics, 1991
- Analysis of late complications after rapid hyperfractionated radiotherapy in advanced head and neck cancersInternational Journal of Radiation Oncology*Biology*Physics, 1988
- Accelerated Fractionation in the Radiation Treatment of Head and Neck Cancer—A Critical Comparison of Different StrategiesActa Oncologica, 1988
- Treatment of advanced head and neck cancer with concomitant radiation and chemotherapyInternational Journal of Radiation Oncology*Biology*Physics, 1987
- Potential for increasing the differential response between tumors and normal tissues: Can proliferation rate be used?International Journal of Radiation Oncology*Biology*Physics, 1986
- Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-fluorouracil or ftorafur and X raysInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Combined therapy for cancer of the anal canalDiseases of the Colon & Rectum, 1981
- Radiotherapy with thrice-a-day fractionation in a short overall time: Clinical experiencesInternational Journal of Radiation Oncology*Biology*Physics, 1981
- Combined radiation therapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx: a randomized studyAmerican Journal of Roentgenology, 1976